홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

FK-352

HCID 6442241
새 반응
인쇄
기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
143881-08-7
표준 SMILES
O=C(O)C[C@H]1CCCCN1C(=O)/C=C/c1c(-c2ccccc2)nn2ccccc12
InChIKey
UWTYIJJJSYDUQM-QFQMRYFISA-N
분자식
C23H23N3O3
평균 분자량
389.4 g/mol
단동위원소 질량
389.1739416

개요

FK352B is a adenosine A1 antagonist that is developed for the treatment of dialysis-induced hypotension.

이름 및 식별자

우선 이름
FK-352
IUPAC
2-[(2R)-1-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)prop-2-enoyl]piperidin-2-yl]acetic acid

이름 및 동의어

FK-352143881-08-7FK-352BH7CU6R2QEXFK 352(R)-1-((E)-3-(2-Phenylpyrazolo(1,5-a)pyridin-3-yl)acryloyl)-piperidin-2-ylacetic acidFK352RefChem:140520UNII-H7CU6R2QEXorb1738832SCHEMBL2829060UWTYIJJJSYDUQM-QFQMRYFISA-N
이름 더 보기
EBC-248093(R,E)-2-(1-(3-(2-Phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl)piperidin-2-yl)acetic acid2-((2R)-1-((2E)-3-(2-PHENYLPYRAZOLO(1,5-A)PYRIDIN-3-YL)PROP-2-ENOYL)PIPERIDIN-2-YL)ACETIC ACID2-PIPERIDINEACETIC ACID, 1-((2E)-1-OXO-3-(2-PHENYLPYRAZOLO(1,5-A)PYRIDIN-3-YL)-2-PROPEN-1-YL)-, (2R)-2-Piperidineacetic acid, 1-((2E)-1-oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-2-propenyl)-, (2R)-2-Piperidineacetic acid, 1-(1-oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-2-propenyl)-, (R-(E))-

데이터베이스 식별자

CAS
143881-08-7
PubChem CID
6442241
UNII
H7CU6R2QEX
Nikkaji
J895.813K

물성

구조 계산 물성

XLogP
3
극성 표면적
74.9 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
4
회전 가능 결합 수
5
무거운 원자 수
29
형식 전하
0
복잡도
616

화학 및 산업

약리 정보

Mechanism of Action · 1건

Intradialytic hypotension is a most frequent complication of hemodialysis and may contribute to cardiovascular events and high mortality. There is a hypothesis that an increase in adenosine generation during hemodialysis may cause vasodilation and a decrease in cardiac output, which results in systemic hypotension. The A1 receptors, which are reported to be distributed in the ends of sympathetic nerves, suppress the release of catecholamines from the ends of the nerves. Adenosine selectively inhibits contractions of the rabbit portal vein evoked by adrenergic nerve stimulation via activation of an A1 receptor. This means that adenosine could inhibit constriction of peripheral vessels via the A1 receptors in the ends of the nerves. FK352, a highly selective A1 adenosine receptor antagonist, significantly attenuated LPS-induced reductions in renal blood flow and mean arterial pressure. It may restore the adenosine-induced decline in constriction.

관련 반응

2건
반응 기록 만들기
HRID 348776 반응식
HRID 348776반응물로
HRID 553325 반응식
HRID 553325반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트